Physician profile
Craig J Eichler
NPI 1548211345
$8,792.43
in general payments reported to CMS, 2019-2025
35 companies · $522 in 2025
The $522 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,075 · 2020: $461 · 2021: $708 · 2022: $1,041 · 2023: $1,762 · 2024: $1,223 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,266 · Education: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,265.67 |
| Education | $240.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $2,919.62 | 2019-2025 | Ilumya, Blu-U, Absorica Ld |
| Janssen Biotech, INC. | $891.98 | 2019-2025 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $723.39 | 2019-2025 | |
| Lilly USA, LLC | $612.18 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $608.21 | 2019-2025 | |
| Epsfl, LLC | $489.38 | 2023 | |
| Galderma Laboratories, L.P. | $372.07 | 2019-2025 | Nemluvio |
| Pfizer INC. | $360.34 | 2019-2025 | |
| Genzyme Corporation | $238.44 | 2019-2025 | |
| Leo Pharma INC. | $226.24 | 2020-2025 | Adbry |
| Celgene Corporation | $165.63 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $151.24 | 2019-2023 | Valchlor |
| Amgen INC. | $113.84 | 2020-2025 | Otezla, Otezla |
| Genentech USA, INC. | $93.27 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $88.53 | 2019-2024 | Libtayo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dusa Pharmaceuticals, INC. | $86.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $86.19 | 2022-2024 | Sotyktu |
| Incyte Corporation | $77.87 | 2021-2023 | Opzelura |
| Ucb, INC. | $54.43 | 2021-2023 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $48.59 | 2023 | |
| Almirall LLC | $45.03 | 2021-2023 | Seysara |
| Arthrex, INC. | $45.00 | 2019 | |
| Biofrontera INC. | $37.31 | 2021-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Kerecis Limited | $35.54 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Merz North America, INC. | $33.18 | 2021-2024 | |
| Dermavant Sciences, INC. | $31.91 | 2024 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.97 | 2023 | Spevigo |
| Sanofi-Aventis U.S. LLC | $19.87 | 2021 | |
| Lnhc, INC | $19.63 | 2025 | Zelsuvmi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.30 | 2022 | |
| Dermira, INC. | $17.97 | 2019 | |
| Aclaris Therapeutics, INC. | $16.89 | 2019 | |
| Convatec INC. | $14.91 | 2024 | |
| Strata Skin Sciences, INC. | $14.44 | 2025 | Xtrac |
| Mylan Pharmaceuticals INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Eichler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.